Your browser doesn't support javascript.
loading
Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency.
Schindler, Christina; Collinson, Andie; Matthews, Carl; Pointon, Amy; Jenkinson, Lesley; Minter, Ralph R; Vaughan, Tristan J; Tigue, Natalie J.
Afiliación
  • Schindler C; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.
  • Collinson A; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.
  • Matthews C; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.
  • Pointon A; Mechanistic Safety and ADME Sciences, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • Jenkinson L; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.
  • Minter RR; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.
  • Vaughan TJ; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.
  • Tigue NJ; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd., Cambridge, United Kingdom.
PLoS One ; 14(3): e0214545, 2019.
Article en En | MEDLINE | ID: mdl-30925190
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Exosomas Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Exosomas Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido